Clinical Trial Update: A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Sativex for pain relief in patients with advanced malignancy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Pain
• Palliative Care

Drugs mentioned

• Sativex (nabiximol)

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Palliative Care, Pain | Phase 3 | Status: COMPLETED | Results posted: 2012-08-13